Recently, the Category 1.1 innovative traditional Chinese medicine Children's Zibei Xuanfei Syrup of Jianmin Pharmaceutical Group Co., Ltd. is approved for marketing by China NMPA.

　　This drug has undergone a randomized, double blind, parallel controlled multi-center clinical trial. The results of clinical trial study showed statistical difference to the placebo control group. This drug is to disperse wind heat, promote lung health, and relieve cough for children with acute trachea-bronchitis with wind-heat invading lung syndrome, with coughing, sweating, throat pain, thirst, thin and yellow tongue coating, and floating and rapid pulse. The marketing of this drug provides new treatment options for relieving cough for children with acute trachea-bronchitis.